IC for the people – 25 years of Metrohm ion chromatography
Metrohm AG
US Senate votes on FDA safety and innovation act
 |
The US FDA will have more powers to inspect ‘risky’ overseas pharmaceutical plants according to supporters of a bill being considered by the US senate this week. Related news |
News in brief
Codexis strengthens relationship with Merck & Co
Industrial enzyme developer Codexis has had its supply contract extended by Merck & Co and been granted key patents for its Hep-C enzymes.
USP and FDA fattens-up QA standards for heparin
The US Pharmacopeial Convention (USP) and the FDA are calling for stricter quality standards for the production and supply of heparin.
People on the move: jobs in pharma
in-PharmaTechnologist presents its latest round-up of new appointments in the pharmaceutical industry, including news from Lanthes, Provectus and Achillon.
Global Industry News
Recipharm says loan will fund takeovers and investment from Outsourcing-Pharma.com
Contract manufacturer Recipharm says a new loan will fund strategic acquisitions and investment in manufacturing facilities.
SGS buys Scottish biotesting firm Vitrology from Outsourcing-Pharma.com
SGS has bought Scottish contract biosafety testing firm Vitrology with an eye on the biologics services market.
Almac sets blister pack investment in context of dynamic US market from Outsourcing-Pharma.com
The compliance and branding advantages of blister packs will shift the US pharmaceutical market away from traditional bottle formats says Almac.
Hot topics
Spotlight
  ICH sends Q11 guidelines to EU, US & Japanese regulatorsThe ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union... |
  in-Pharmatechnologist.com's review of Interphex 2012in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak... |
 Effective controls still lacking for continuous processing says Interphex panelContinuous processing is still hamstrung by a lack of control systems and is not ready for specific... |
 BASF buys omega-3 maker Equateq citing pharma potentialBASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key... |
 EMA outlines manufacturing quality docs for biologics trialsThe EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials. |